You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Overview

  • Product nameAnti-LC3B antibodySee all LC3B primary antibodies ...
  • Description
    Rabbit polyclonal to LC3B
  • Specificityab51520 is specific for the B isoform of LC3.
  • Tested applicationsIHC - Wholemount, IHC-Fr, WB, ICC/IF more details
  • Species reactivity
    Reacts with: Mouse, Human
  • Immunogen

    Synthetic peptide made to the N terminal region of human LC3, isoform B protein.

  • Positive controlWB: Treated U87-MG lysates. ICC/IF: Treated U87-MG cells. human malignant brain tumors, breast cancer, leukemia samples and murine cells
  • General notes


    ab51520 has been shown to work on human malignant brain tumors, breast cancer, leukemia samples, and murine cells.

Properties

Applications

Our Abpromise guarantee covers the use of ab51520 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Notes
IHC - Wholemount IHC - Wmt: Use at an assay dependent concentration.
IHC-Fr IHC-Fr: 1/2000.
WB WB: 1/3000. Predicted molecular weight: 15 kDa. Detects bands of ~16 kDa (LC3-II) and ~18 kDa (LC3-I).
ICC/IF ICC/IF: 1/2000.

Target

  • FunctionProbably involved in formation of autophagosomal vacuoles (autophagosomes).
  • Tissue specificityMost abundant in heart, brain, skeletal muscle and testis. Little expression observed in liver.
  • Sequence similaritiesBelongs to the MAP1 LC3 family.
  • Post-translational
    modifications
    The precursor molecule is cleaved by APG4B/ATG4B to form LC3-I. This is activated by APG7L/ATG7, transferred to ATG3 and conjugated to phospholipid to form LC3-II.
  • Cellular localizationCytoplasm > cytoskeleton. Endomembrane system. Cytoplasmic vesicle > autophagosome membrane. LC3-II binds to the autophagic membranes.
  • Target information above from: UniProt accession Q9GZQ8 The UniProt Consortium
    The Universal Protein Resource (UniProt) in 2010
    Nucleic Acids Res. 38:D142-D148 (2010) .

    Information by UniProt
  • Database links
  • Alternative names
      ATG8F antibodyAutophagy related protein LC3 B antibodyAutophagy related ubiquitin like modifier LC3 B antibody
      Autophagy-related protein LC3 B antibodyAutophagy-related ubiquitin-like modifier LC3 B antibodyLC3B antibodyMAP1 light chain 3 like protein 2 antibodyMAP1 light chain 3-like protein 2 antibodyMAP1A/1B light chain 3 B antibodyMAP1A/1BLC3 antibodyMAP1A/MAP1B LC3 B antibodyMAP1A/MAP1B light chain 3 B antibodyMAP1ALC3 antibodyMAP1LC3B a antibodyMAP1LC3B antibodyMicrotubule associated protein 1 light chain 3 beta antibodyMicrotubule associated proteins 1A/1B light chain 3B antibodyMicrotubule-associated protein 1 light chain 3 beta antibodyMicrotubule-associated proteins 1A/1B light chain 3B antibodyMLP3B_HUMAN antibody
    see all

Anti-LC3B antibody images

  • All lanes : Anti-LC3B antibody (ab51520) at 1/3000 dilution

    Lane 1 : treated U87-MG (human glioblastoma astrocytoma) lysates with Arsenic Trioxide at 0 µM
    Lane 2 : treated U87-MG (human glioblastoma astrocytoma) lysates with Arsenic Trioxide at 2 µM
    Lane 3 : treated U87-MG (human glioblastoma astrocytoma) lysates with Arsenic Trioxide at 4 µM
    Lane 4 : treated U87-MG (human glioblastoma astrocytoma) lysates with Arsenic Trioxide at 8 µM


    Predicted band size : 15 kDa
  • Ab51520 at 1/2000 dilution staining treated U373-MG cells;
    1) Control
    2) C2-ceramide.
    The nuclei were stained with DAPI.
  • Ab51520 at 1/2000 dilution staining treated U373-MG (human glioblastoma) cells
    1) Control
    2) Temozolomide
  • Ab51520 at 1/2000 dilution staining treated U87-MG cultured and subcutaneous tumors
    1) Control
    2) Temozolomide
  • Ab51520 at 1/2000 dilution staining gliobastoma multiform tissue
    1) normal brain
    2) gliobastoma multiform tissue

References for Anti-LC3B antibody (ab51520)

This product has been referenced in:
  • Ma Y  et al. Toll-like receptor (TLR) 2 and TLR4 differentially regulate doxorubicin induced cardiomyopathy in mice. PLoS One 7:e40763 (2012). WB ; Mouse . Read more (PubMed: 22808256) »
  • Vandergaast R & Fredericksen BL West Nile Virus (WNV) Replication Is Independent of Autophagy in Mammalian Cells. PLoS One 7:e45800 (2012). WB . Read more (PubMed: 23029249) »

See all 6 Publications for this product

Product Wall

Filter by Application

Filter by Species

Filter by Ratings

Western blot

Excellent
Abreviews
Application Western blot
Loading amount 30 µg
Gel Running Conditions Reduced Denaturing (15% SDS-PAGE gel)
Sample Human Cell lysate - whole cell (HeLa cells)
Specification HeLa cells
Treatment HeLa cells without or with 50 uM chloroquine for 18 hrs
Blocking step Milk as blocking agent for 30 minute(s) · Concentration: 5% · Temperature: 25°C
Username

Verified customer

Submitted Jun 12 2013

Application Western blot
Sample Mouse Tissue lysate - whole (uterus, placenta)
Loading amount 50 µg
Specification uterus, placenta
Treatment LPS
Gel Running Conditions Reduced Denaturing (4-12)
Blocking step Milk as blocking agent for 1 hour(s) and 0 minute(s) · Concentration: 5% · Temperature: 28°C
Username

Verified customer

Submitted May 14 2013

Application IHC - Wholemount
Sample Zebrafish Embryo (Muscle)
Specification Muscle
Username

Verified customer

Submitted May 02 2013

Application Western blot
Sample Human Cell lysate - whole cell (breast cancer cells)
Loading amount 60 µg
Specification breast cancer cells
Treatment DIM-CF3 + wortmannin
Gel Running Conditions Reduced Denaturing (12)
Blocking step Milk as blocking agent for 30 minute(s) · Concentration: 5% · Temperature: 25°C
Username

Verified customer

Submitted Nov 12 2010

Application Western blot
Sample Human Cell lysate - whole cell (Human breast carcinoma and Human embryonic Kidney)
Loading amount 20 µg
Specification Human breast carcinoma and Human embryonic Kidney
Gel Running Conditions Reduced Denaturing (12% acrylamide)
Blocking step Milk as blocking agent for 1 hour(s) and 0 minute(s) · Concentration: 5% · Temperature: 22°C
Username

Verified customer

Submitted Mar 17 2010

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"